1. Home
  2. PRQR vs WENC Comparison

PRQR vs WENC Comparison

Compare PRQR & WENC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo ProQR Therapeutics N.V.

PRQR

ProQR Therapeutics N.V.

HOLD

Current Price

$1.73

Market Cap

166.5M

Sector

Health Care

ML Signal

HOLD

WENC

West Enclave Merger Corp. Ordinary Shares

N/A

Current Price

$9.96

Market Cap

159.2M

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
PRQR
WENC
Founded
2012
N/A
Country
Netherlands
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Blank Checks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
166.5M
159.2M
IPO Year
2014
2026

Fundamental Metrics

Financial Performance
Metric
PRQR
WENC
Price
$1.73
$9.96
Analyst Decision
Strong Buy
Analyst Count
4
0
Target Price
$7.25
N/A
AVG Volume (30 Days)
1.6M
23.5K
Earning Date
05-07-2026
N/A
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$13.92
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.33
$9.89
52 Week High
$3.10
$9.96

Technical Indicators

Market Signals
Indicator
PRQR
WENC
Relative Strength Index (RSI) 52.17 67.50
Support Level $1.39 $9.89
Resistance Level $2.03 N/A
Average True Range (ATR) 0.19 0.01
MACD -0.00 0.01
Stochastic Oscillator 58.73 100.00

Price Performance

Historical Comparison
PRQR
WENC

About PRQR ProQR Therapeutics N.V.

ProQR Therapeutics NV is a biopharmaceutical company. It discovers and develops RNA therapeutics for patients with severe genetic rare diseases such as cystic fibrosis, Leber congenital amaurosis type 10, and dystrophic epidermolysis bullosa. The only reportable segment of the company is the discovery and development of different, RNA-based therapeutics. Geographically, the company operates in United States.

About WENC West Enclave Merger Corp. Ordinary Shares

West Enclave Merger Corp is a blank check company.

Share on Social Networks: